Loading clinical trials...
Loading clinical trials...
Phase II, Open Label, Dose Finding Study of the Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer Compared to a Luteinizing Hormone Releasing Hormone Agonist
Conditions
Interventions
GTx-758 1000mg
Lupron Depot
+1 more
Locations
36
United States
GTx Investigative Site
Phoenix, Arizona, United States
GTx Investigative Site
La Mesa, California, United States
GTx Investigative Site
Los Angeles, California, United States
GTx Investigative Site
San Bernardino, California, United States
GTx Investigative Site
Middlebury, Connecticut, United States
GTx Investigative Site
Aventura, Florida, United States
Start Date
June 1, 2011
Primary Completion Date
December 1, 2012
Completion Date
December 1, 2012
Last Updated
June 22, 2023
NCT06844383
NCT06926283
NCT06594926
NCT07177937
NCT05919264
NCT06487507
Lead Sponsor
GTx
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions